Naoko Matsushita Selected Research

3- (3- (4- (3- (glucopyranosyloxy)- 5- isopropyl- 1H- pyrazol- 4- ylmethyl)- 3- methylphenoxy)propylamino)propionamide

1/2020

Pretreatment with KGA-2727, a selective SGLT1 inhibitor, is protective against myocardial infarction-induced ventricular remodeling and heart failure in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Naoko Matsushita Research Topics

Disease

5	Fibrosis (Cirrhosis) 01/2020 - 01/2012
3	Ischemia 01/2020 - 01/2014
3	Cardiomyopathies (Cardiomyopathy) 01/2020 - 01/2014
3	Heart Failure 01/2020 - 01/2012
3	Hypertrophy 09/2018 - 01/2014
2	Ventricular Premature Complexes (Premature Ventricular Contraction) 01/2014 - 01/2012
2	Ventricular Tachycardia 01/2014 - 01/2014
2	Cardiac Arrhythmias (Arrythmia) 01/2014 - 01/2012
1	Polyneuropathies (Polyneuropathy) 01/2022
1	Ventricular Remodeling 01/2020
1	Myocardial Infarction 01/2020
1	Atrial Remodeling 01/2019
1	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 09/2018
1	Cardiomegaly (Heart Hypertrophy) 09/2018
1	Body Weight (Weight, Body) 09/2018
1	Tachycardia (Tachyarrhythmias) 01/2015
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2012
1	Necrosis 11/2002

Drug/Important Bio-Agent (IBA)

2	salicylhydroxamic acid (SHAM)IBA 01/2020 - 09/2018
2	Sodium-Glucose Transporter 1IBA 09/2018 - 01/2018
2	Nicorandil (SG 75)IBA 01/2014 - 01/2012
2	Polyvinyl Chloride (PVC)IBA 01/2014 - 01/2012
1	Prealbumin (Transthyretin)IBA 01/2022
1	Glucose (Dextrose)FDA LinkGeneric 01/2020
1	SymportersIBA 01/2020
1	3- (3- (4- (3- (glucopyranosyloxy)- 5- isopropyl- 1H- pyrazol- 4- ylmethyl)- 3- methylphenoxy)propylamino)propionamideIBA 01/2020
1	SodiumIBA 01/2020
1	InflammasomesIBA 01/2019
1	Adrenergic Agents (Adrenergic Drugs)IBA 09/2018
1	Interleukin-18 (Interleukin 18)IBA 09/2018
1	Phenylephrine (Neo-Synephrine)FDA LinkGeneric 09/2018
1	Adenosine Triphosphate (ATP)IBA 01/2015
1	PhlorhizinIBA 01/2014
1	DesminIBA 01/2014
1	Angiotensin IIIBA 01/2014
1	Type 1 Angiotensin ReceptorIBA 01/2014
1	olmesartanIBA 01/2014
1	Cephaloridine (Cefaloridine)IBA 11/2002
1	Electron Transport Complex IV (Cytochrome c Oxidase)IBA 11/2002

Therapy/Procedure

1	Therapeutics 01/2020